Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • SEC-seq Reveals VEGF-A Secretion Heterogeneity in MSCs

    2026-06-21

    SEC-seq Reveals VEGF-A Secretion Heterogeneity in Mesenchymal Stromal Cells

    Study Background and Research Question

    Cellular secretion of bioactive molecules underpins many physiological and therapeutic processes, yet most methods for analyzing protein secretion aggregate data across populations, masking crucial cell-to-cell heterogeneity. Mesenchymal stromal cells (MSCs) are of particular interest due to their capacity to secrete cytokines, growth factors, and other modulators relevant for regenerative medicine. One of the most clinically relevant factors, vascular endothelial growth factor A (VEGF-A), mediates angiogenesis and tissue repair. Understanding which MSCs secrete VEGF-A and how secretion is regulated at the single-cell level is vital for advancing cell-based therapies. However, previous approaches have lacked the scalability and sensitivity to link secretory function to transcriptional states in individual cells, especially for adherent cell types like MSCs (Udani et al., 2023).

    Key Innovation from the Reference Study

    The reference study introduces secretion encoded single-cell sequencing (SEC-seq), a platform that integrates hydrogel nanovials for isolating single cells and their secretions with high-throughput single-cell RNA sequencing. This methodology enables researchers to simultaneously quantify secreted proteins and the transcriptome of thousands of individual MSCs—an advance over prior single-cell secretion assays, which either lacked transcriptional linkage (e.g., ELISpot) or were not compatible with adherent cells (Udani et al., 2023). By combining functional phenotyping with transcriptomic profiling, SEC-seq provides a powerful tool for dissecting cellular heterogeneity in secretory behaviors.

    Methods and Experimental Design Insights

    SEC-seq leverages hydrogel nanovials, which are microscale particles with engineered cavities capable of capturing single MSCs. Individual cells are loaded into nanovials, where secreted proteins such as VEGF-A are captured by co-localized antibody reagents. After a defined secretion period, the nanovials are stained with fluorescently labeled antibodies targeting VEGF-A, enabling quantification of secreted protein via fluorescence-activated cell sorting (FACS). Nanovials containing single cells are then subjected to single-cell RNA sequencing, allowing for direct linkage of secretion phenotype and transcriptomic state. Importantly, the method preserves cell viability and mRNA integrity, which is often compromised by fixation or permeabilization in traditional intracellular staining workflows. The study applied SEC-seq to thousands of MSCs cultured under both normoxic and hypoxic conditions to evaluate both baseline and induced VEGF-A secretion.

    Core Findings and Why They Matter

    SEC-seq revealed substantial heterogeneity in VEGF-A secretion among individual MSCs. Notably, the correlation between VEGF-A secretion at the protein level and VEGFA transcript abundance was low, indicating post-transcriptional regulation and suggesting that mRNA levels alone are insufficient predictors of secretory output. While hypoxic culture modestly increased average VEGF-A secretion across the MSC population, the most pronounced effect was the identification of a distinct subpopulation of cells exhibiting exceptionally high VEGF-A secretion, regardless of culture condition. Transcriptomic analysis of these high-secreting MSCs uncovered unique gene expression signatures, pointing to specific regulatory networks that may govern secretory potency. These insights have significant implications for cell therapy manufacturing, as sorting or engineering for high-secretion phenotypes could enhance therapeutic efficacy (Udani et al., 2023).

    Comparison with Existing Internal Articles

    Internal thought-leadership and technical articles on Sulfo-NHS-Biotin and related reagents have emphasized the importance of precise, water-soluble, amine-reactive biotinylation in advanced proteomic and single-cell workflows. For example, "Sulfo-NHS-Biotin: Water-Soluble, Amine-Reactive Protein Labeling" describes the reagent’s advantages for selective cell surface protein labeling and downstream affinity workflows. Similarly, "Next-Gen Protein Labeling for Single-Cell Secretome Analysis" discusses the growing role of water-soluble biotinylation reagents in secretome profiling and functional genomics. The SEC-seq workflow complements these insights by operationalizing the linkage between functional secretion and transcriptomics at single-cell resolution, and may benefit from the robust, membrane-impermeant labeling strategies highlighted in these technical resources.

    Limitations and Transferability

    While SEC-seq offers a transformative approach to coupling secretory profiling with transcriptomics, several limitations should be noted. The method relies on the efficiency and specificity of antibody capture for secreted proteins, which may not be equally effective for all analytes. Throughput and resolution are influenced by nanovial design and cell loading statistics, potentially limiting detection of rare events. Additionally, while the study focused on MSCs and VEGF-A, adaptation to other cell types and secreted factors may require reagent optimization. As with any high-dimensional single-cell method, careful protocol controls and validation are necessary for robust interpretation and reproducibility.

    Protocol Parameters

    • Nanovial loading: Optimize cell concentration to favor single-cell occupancy per nanovial, minimizing doublets.
    • Secretion capture window: Empirically determine optimal incubation time for each secreted protein; the reference study used a timescale sufficient to detect VEGF-A above background.
    • Antibody labeling: Use fluorescently labeled antibodies validated for specificity and sensitivity to the target secreted protein.
    • Single-cell sequencing: Ensure mRNA integrity by avoiding fixation/permeabilization prior to sequencing.
    • For protein surface labeling (e.g., cell surface markers): Use water-soluble protein labeling reagents that do not penetrate the plasma membrane, such as Sulfo-NHS-Biotin, at 2 mM in phosphate buffer (pH 7.5) with NaCl, incubated at room temperature for 30 minutes (product information).

    Research Support Resources

    To facilitate single-cell secretome analysis or cell surface protein profiling in similar workflows, researchers can incorporate Sulfo-NHS-Biotin (SKU A8001), a water-soluble, amine-reactive biotinylation reagent that selectively labels cell surface proteins without membrane penetration. Its use is well suited to affinity chromatography, immunoprecipitation, and secretome capture approaches, as discussed in APExBIO’s technical resources and in the SEC-seq context. Proper reagent selection and protocol optimization are critical for maximizing data quality and biological insight in advanced single-cell and proteomic studies.